X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (70) 70
Patent (11) 11
Book Review (6) 6
Conference Proceeding (4) 4
Newspaper Article (4) 4
Book / eBook (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (44) 44
humans (40) 40
female (27) 27
oncology (17) 17
receptors, urokinase plasminogen activator (14) 14
peptides (13) 13
prognosis (13) 13
urokinase-type plasminogen activator - metabolism (13) 13
chemistry (12) 12
animals (11) 11
beer (11) 11
biochemistry (11) 11
breast neoplasms - pathology (11) 11
compositions thereof (11) 11
culture media (11) 11
enzymology (11) 11
human necessities (11) 11
hygiene (11) 11
investigating or analysing materials by determining theirchemical or physical properties (11) 11
measuring (11) 11
medical or veterinary science (11) 11
metallurgy (11) 11
microbiology (11) 11
microorganisms or enzymes (11) 11
mutation or genetic engineering (11) 11
organic chemistry (11) 11
physics (11) 11
preparations for medical, dental, or toilet purposes (11) 11
propagating, preserving or maintaining microorganisms (11) 11
receptors, cell surface - metabolism (11) 11
spirits (11) 11
testing (11) 11
vinegar (11) 11
wine (11) 11
biochemistry & molecular biology (10) 10
degradation (10) 10
invasion (10) 10
metastasis (10) 10
middle aged (10) 10
receptor (10) 10
upa (10) 10
compositions or test papers therefor (9) 9
condition-responsive control in microbiological orenzymological processes (9) 9
measuring or testing processes involving enzymes, nucleicacids or microorganisms (9) 9
processes of preparing such compositions (9) 9
specific therapeutic activity of chemical compounds ormedicinal preparations (9) 9
breast cancer (8) 8
tumor cells, cultured (8) 8
adult (7) 7
aged (7) 7
molecular sequence data (7) 7
urokinase-type plasminogen activator - antagonists & inhibitors (7) 7
amino acid sequence (6) 6
breast neoplasms - mortality (6) 6
carcinoma (6) 6
cells (6) 6
early relapse (6) 6
expression (6) 6
ovarian cancer (6) 6
pai-1 (6) 6
therapy (6) 6
urokinase-type plasminogen activator - analysis (6) 6
abridged index medicus (5) 5
breast neoplasms - chemistry (5) 5
breast-cancer (5) 5
lymphatic metastasis (5) 5
mice (5) 5
neoplasm invasiveness (5) 5
receptors, cell surface - genetics (5) 5
recombinant proteins - metabolism (5) 5
risk factors (5) 5
survival analysis (5) 5
transfection (5) 5
tumor invasion (5) 5
urokinase-type plasminogen activator (5) 5
urokinase-type plasminogen activator - genetics (5) 5
aged, 80 and over (4) 4
binding (4) 4
cancer (4) 4
cell biology (4) 4
cho cells (4) 4
congresses (4) 4
cricetinae (4) 4
hematology (4) 4
immunohistochemistry (4) 4
molecular weight (4) 4
neoplasm staging (4) 4
plasminogen activator (4) 4
plasminogen activator inhibitor 1 - analysis (4) 4
plasminogen activators - metabolism (4) 4
plasminogen-activator (4) 4
predictive value of tests (4) 4
protein binding (4) 4
receptors (4) 4
survival (4) 4
system (4) 4
time factors (4) 4
antibodies, monoclonal (3) 3
antigen (3) 3
binding sites (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 2001, Volume 93, Issue 12, pp. 913- - 9120
Journal Article
1980, Authorized, completely rev. and enl. English ed. --, Major problems in obstetrics and gynecology, ISBN 9780721641928, Volume 13, xviii, 162
Book
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 03/2001, Volume 21, Issue 6, pp. 2118 - 2132
Migration of cells requires interactions with the extracellular matrix mediated, in part, by integrins, proteases, and their receptors. Previous studies have... 
Cell Growth and Development
Journal Article
Journal Article
Cancer Gene Therapy, ISSN 0929-1903, 2000, Volume 7, Issue 2, pp. 292 - 299
The serine protease urokinase-type plasminogen activator, uPA, when bound to its specific receptor, uPAR (CD87), plays a significant role in tumor cell... 
uPA | Tumor | Breast cancer | Soluble uPA receptor | Metastasis | Plasminogen | CD87 | OVARIAN-CANCER CELLS | SYSTEM | MEDICINE, RESEARCH & EXPERIMENTAL | LOCALIZATION | INVOLVEMENT | breast cancer | PROLIFERATION | METALLOPROTEINASES | plasminogen | INVASION | ONCOLOGY | soluble uPA receptor | metastasis | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | tumor | GENETICS & HEREDITY | INHIBITOR | Humans | Enzyme Precursors - genetics | Lung Neoplasms - pathology | Mammary Neoplasms, Experimental - metabolism | Mammary Neoplasms, Experimental - genetics | Breast Neoplasms - metabolism | Breast Neoplasms - therapy | Receptors, Urokinase Plasminogen Activator | Transfection | Lung Neoplasms - secondary | Mammary Neoplasms, Experimental - pathology | Female | Matrix Metalloproteinase 9 - secretion | Receptors, Cell Surface - biosynthesis | Tumor Cells, Cultured | CHO Cells | Cell Division - genetics | Lung Neoplasms - genetics | Cricetinae | Gene Expression Regulation - genetics | Enzyme Precursors - biosynthesis | Solubility | Enzyme Precursors - secretion | Lung Neoplasms - therapy | Urokinase-Type Plasminogen Activator - genetics | Mammary Neoplasms, Experimental - therapy | Animals | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Mice, Nude | Protein Binding | Matrix Metalloproteinase 2 - secretion | Urokinase-Type Plasminogen Activator - biosynthesis | Mice | Urokinase-Type Plasminogen Activator - secretion | Receptors, Cell Surface - genetics | Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 1995, Volume 1, Issue 7, pp. 741 - 746
The lysosomal cysteine proteases cathepsin B and cathepsin L have been implicated in tumor spread and metastasis, To evaluate the prognostic impact of these... 
ACTIVATOR PRO-UPA | PLASMINOGEN-ACTIVATOR | ONCOLOGY | FORM | EARLY RELAPSE | DEGRADATION | CELL-LINES | EXPRESSION | CARCINOMA | FIBROBLASTS | ANTIGEN
Journal Article
Journal Article
Journal Article
FEBS Letters, ISSN 0014-5793, 1998, Volume 438, Issue 1, pp. 101 - 105
Ovarian cancer metastasis is associated with an increase in the urokinase‐type plasminogen activator (uPA) and its receptor uPAR. We present evidence that... 
Cell proliferation | Urokinase-type plasminogen activator receptor | Urokinase-type plasminogen activator | Mitogen | Antisense transfection | Ovarian cancer | urokinase-type plasminogen activator | urokinase-type plasminogen activator receptor | MIGRATION | PLASMINOGEN-ACTIVATOR UPA | cell proliferation | antisense transfection | ovarian cancer | PHOSPHORYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELLULAR RECEPTOR | TERMINAL FRAGMENT | INDUCTION | CELL BIOLOGY | INVASION | mitogen | INHIBITION | BIOPHYSICS | LINE | EXPRESSION | Urokinase-Type Plasminogen Activator - antagonists & inhibitors | Molecular Weight | Humans | Ovarian Neoplasms - pathology | Plasminogen Activators - metabolism | Peptide Fragments - pharmacology | Type C Phospholipases - pharmacology | Receptors, Urokinase Plasminogen Activator | DNA, Neoplasm - biosynthesis | Transfection | Lymphocytes | Female | Urokinase-Type Plasminogen Activator - chemistry | Tumor Cells, Cultured | Peptide Fragments - metabolism | Plasminogen Activators - chemistry | Receptors, Cell Surface - metabolism | Antibodies, Monoclonal | Receptors, Cell Surface - immunology | Cell Division - drug effects | Ovarian Neoplasms - enzymology | DNA, Antisense | Urokinase-Type Plasminogen Activator - metabolism | Protein Binding | Plasminogen Activators - pharmacology | Cell Cycle - drug effects | Urokinase-Type Plasminogen Activator - pharmacology | Index Medicus
Journal Article